|
US2014308668A1
|
|
Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes SImplex Virus
|
|
US2013225657A1
|
|
SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment
|
|
US2014057960A1
|
|
Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
|
|
US2013130253A1
|
|
Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorphisms
|
|
US2013115599A1
|
|
Increased cip2a expression and bladder cancer in humans
|
|
US2013288238A1
|
|
Methods and compositions for detecting serotypes of Chlamydia trachomatis capable of causing lymphogranuloma venereum
|
|
US2011237643A1
|
|
Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity
|
|
EP2326660A2
|
|
Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae
|
|
WO2010021846A2
|
|
Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae
|
|
US2010092959A1
|
|
Single nucleotide polymorphisms as genetic markers for childhood leukemia
|
|
US2009305274A1
|
|
Method for determining azole resistance in Candida glabrata
|
|
US2009246767A1
|
|
Compositions and methods for detecting cryptococcus neoformans
|
|
US2009275023A1
|
|
Compositions and methods for detecting Borrelia afzelii
|
|
US2008220458A1
|
|
Antibodies specific to antigens of Bartonella henselae and use of these antigens in immunoassays
|
|
US2008038726A1
|
|
Compositions and methods for detecting Atopobium vaginae
|
|
US2006088865A1
|
|
Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents
|
